WO2012011673A3 - 헤스페레틴을 유효성분으로 포함하는 근육세포 분화 또는 재생 촉진용 약학적 조성물 - Google Patents

헤스페레틴을 유효성분으로 포함하는 근육세포 분화 또는 재생 촉진용 약학적 조성물 Download PDF

Info

Publication number
WO2012011673A3
WO2012011673A3 PCT/KR2011/004560 KR2011004560W WO2012011673A3 WO 2012011673 A3 WO2012011673 A3 WO 2012011673A3 KR 2011004560 W KR2011004560 W KR 2011004560W WO 2012011673 A3 WO2012011673 A3 WO 2012011673A3
Authority
WO
WIPO (PCT)
Prior art keywords
renewal
cell differentiation
muscle cell
pharmaceutical composition
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/004560
Other languages
English (en)
French (fr)
Other versions
WO2012011673A2 (ko
Inventor
황은숙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ewha Womans University
Original Assignee
Ewha Womans University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ewha Womans University filed Critical Ewha Womans University
Publication of WO2012011673A2 publication Critical patent/WO2012011673A2/ko
Publication of WO2012011673A3 publication Critical patent/WO2012011673A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 근육세포 분화 또는 재생 촉진제, 근육장애 치료 또는 예방용 약학 조성물, 근육장애 개선 또는 억제용 식품 조성물을 제공한다. 본 발명의 촉진제는 근육 세포 분화와 재생에 효과적이며, 본 발명의 조성물은 근육장애 치료(개선) 또는 예방에 효과적이다.
PCT/KR2011/004560 2010-07-20 2011-06-22 헤스페레틴을 유효성분으로 포함하는 근육세포 분화 또는 재생 촉진용 약학적 조성물 Ceased WO2012011673A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100070186A KR20120009726A (ko) 2010-07-20 2010-07-20 근육세포 분화 또는 재생 촉진제
KR10-2010-0070186 2010-07-20

Publications (2)

Publication Number Publication Date
WO2012011673A2 WO2012011673A2 (ko) 2012-01-26
WO2012011673A3 true WO2012011673A3 (ko) 2012-05-03

Family

ID=45497252

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/004560 Ceased WO2012011673A2 (ko) 2010-07-20 2011-06-22 헤스페레틴을 유효성분으로 포함하는 근육세포 분화 또는 재생 촉진용 약학적 조성물

Country Status (2)

Country Link
KR (1) KR20120009726A (ko)
WO (1) WO2012011673A2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150071932A (ko) * 2013-12-19 2015-06-29 이화여자대학교 산학협력단 Taz 단백질 활성화 유도 성분을 포함하는 근육 분화 및 근육재생용 약학적 조성물
EP3132692A1 (en) * 2015-03-24 2017-02-22 Biosens Croatia Compositions comprising small molecular inhibitors suitable to inhibit and stimulate signaling pathways in a manner leading to prevention of muscle atrophy
KR102802853B1 (ko) * 2021-02-26 2025-05-07 이엑스헬스케어 주식회사 피부 유래 엑소좀을 통해 근손실 억제 또는 근생성 촉진 효과를 나타내는 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009007313A (ja) * 2007-06-29 2009-01-15 Lion Corp 筋萎縮抑制剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009007313A (ja) * 2007-06-29 2009-01-15 Lion Corp 筋萎縮抑制剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JIN, Y. -R. ET AL.: "Hesperetin, a bioflavonoid, inhibits rat aortic vascular smooth muscle cells proliferation by arresting cell cycle", JOURNAL OF CELLULAR BIOCHEMISTRY, vol. 104, no. 1, 2008, pages 1 - 14 *

Also Published As

Publication number Publication date
KR20120009726A (ko) 2012-02-02
WO2012011673A2 (ko) 2012-01-26

Similar Documents

Publication Publication Date Title
IN2012DN00624A (ko)
WO2011090270A3 (ko) 오스모틴을 포함하는 신경질환의 예방 및 치료용 조성물
WO2012009715A3 (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection
WO2010087565A3 (ko) 피페린의 신규한 용도
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2012145651A3 (en) Compounds for the treatment of neuropsychiatric disorders
IL215444A0 (en) Novel p2x7r antagonists and their use
MX350746B (es) Derivados de ciclosporina novedosos para el tratamiento y la prevención de una infección viral.
WO2011076367A3 (en) Synergistic antiviral composition and use thereof
MX2012008890A (es) Composicion de combinacion, que comrpende como ingrediente activo l-carnitina o propionil l-carnitina, para la prevencion o tratamiento de insuficiencia venosa cronica.
WO2012021818A3 (en) Ggf2 and methods of use
EP2583969A4 (en) NEW RHODANINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS WITH THE RHODANIN DERIVATIVES AS ACTIVE AGENTS
WO2011136573A3 (ko) 비만 치료 및 항산화 활성을 갖는 효모 가수분해물
WO2010013975A3 (en) A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivative or its salt, and bisphosphonate
WO2012011673A3 (ko) 헤스페레틴을 유효성분으로 포함하는 근육세포 분화 또는 재생 촉진용 약학적 조성물
WO2013000895A9 (en) Dha and epa in the reduction of oxidative stress
WO2011141113A3 (de) Kombination aus vitamin k und nikotinamid
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
WO2011118957A3 (ko) 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물
WO2010042212A3 (en) Methods for treating or preventing pain using spicamycin derivatives
WO2013005956A3 (ko) 위장관 운동장애 예방 및 개선용 약학 조성물 그리고 식품 조성물
MX2013002398A (es) Inhibidores de beta-secretasa (base) para su uso en tratamiento de diabetes.
WO2011163231A3 (en) Combination therapy for the treatment of diabetes
WO2010101538A3 (en) New crystalline forms of tiotropium bromide
MY170190A (en) Use of a fermented soy extract as a prebiotic composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11809800

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11809800

Country of ref document: EP

Kind code of ref document: A2